A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity
出版年份 2020 全文链接
标题
A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity
作者
关键词
-
出版物
MOLECULES
Volume 25, Issue 11, Pages 2551
出版商
MDPI AG
发表日期
2020-06-03
DOI
10.3390/molecules25112551
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening
- (2019) S. Lamotte et al. Scientific Reports
- Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
- (2019) Susan Wyllie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
- (2018) Susan Wyllie et al. NATURE
- Importance of secondary screening with clinical isolates for anti-leishmania drug discovery
- (2018) Aya Hefnawy et al. Scientific Reports
- Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis
- (2018) Laura M. Alcântara et al. International Journal for Parasitology-Drugs and Drug Resistance
- Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
- (2017) Saumya Srivastava et al. Parasites & Vectors
- Chemotherapy of leishmaniasis: present challenges
- (2017) SILVIA R. B. ULIANA et al. PARASITOLOGY
- Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs
- (2017) Aya Hefnawy et al. TRENDS IN PARASITOLOGY
- Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform
- (2017) Jacob T. Bush et al. PLoS Neglected Tropical Diseases
- Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani
- (2017) Leah S. Torrie et al. ACS Infectious Diseases
- Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box Against Intracellular Leishmania major Amastigotes
- (2016) Mozna Khraiwesh et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- A ReplicativeIn VitroAssay for Drug Discovery against Leishmania donovani
- (2016) Diana Tegazzini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- The immunology of post-kala-azar dermal leishmaniasis (PKDL)
- (2016) Eduard E. Zijlstra Parasites & Vectors
- A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies
- (2016) Mohammad Akhoundi et al. PLoS Neglected Tropical Diseases
- The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
- (2016) Stephen Patterson et al. eLife
- New World and Old World Leishmania Infections
- (2015) Ines Kevric et al. DERMATOLOGIC CLINICS
- The genome of Leishmania panamensis: insights into genomics of the L. (Viannia) subgenus.
- (2015) Alejandro Llanes et al. Scientific Reports
- New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
- (2015) Imanol Peña et al. Scientific Reports
- Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity
- (2015) Andrea Nühs et al. PLoS Neglected Tropical Diseases
- The in vitro leishmanicidal activity of hexadecylphosphocholine (miltefosine) against four medically relevant Leishmania species of Brazil
- (2014) Eliane de Morais-Teixeira et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Miltefosine and Antimonial Drug Susceptibility of Leishmania Viannia Species and Populations in Regions of High Transmission in Colombia
- (2014) Olga Lucía Fernández et al. PLoS Neglected Tropical Diseases
- Evaluating Aziridinyl Nitrobenzamide Compounds as Leishmanicidal Prodrugs
- (2013) Andrew A. Voak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay
- (2013) Manu De Rycker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance
- (2013) Suman Rijal et al. CLINICAL INFECTIOUS DISEASES
- An Essential Type I Nitroreductase fromLeishmania majorCan Be Used to Activate Leishmanicidal Prodrugs
- (2013) Andrew A. Voak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High Content Analysis of Primary Macrophages Hosting Proliferating Leishmania Amastigotes: Application to Anti-leishmanial Drug Discovery
- (2013) Nathalie Aulner et al. PLoS Neglected Tropical Diseases
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular Leishmania donovani Amastigotes in Human Macrophages
- (2012) Jair L. Siqueira-Neto et al. PLoS Neglected Tropical Diseases
- Molecular Mechanisms of Drug Resistance in Natural Leishmania Populations Vary with Genetic Background
- (2012) Saskia Decuypere et al. PLoS Neglected Tropical Diseases
- Central Nervous System Toxicity Associated with Liposomal Amphotericin B Therapy for Cutaneous Leishmaniasis
- (2011) Jessie S. Glasser et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
- (2011) Bidyut Purkait et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trypanocidal Activity of Aziridinyl Nitrobenzamide Prodrugs
- (2010) C. Bot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds
- (2010) Jair L. Siqueira-Neto et al. PLoS Neglected Tropical Diseases
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started